Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | VT103 |
| Trade Name | |
| Synonyms | VT-103|VT 103 |
| Drug Descriptions |
VT103 selectively inhibits TEAD1 palmitoylation, which results in decreased YAP/TAZ signaling and potentially reduces tumor growth (PMID: 33850002). |
| DrugClasses | |
| CAS Registry Number | 2290608-13-6 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Defactinib + VT103 | Defactinib VT103 | 0 | 0 |
| VT103 | VT103 | 0 | 0 |